Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.

JERUSALEM May 17, 2013-Oramed Pharmaceuticals Inc. , a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration has cleared the Company's Investigational New Drug application for ORMD-0801, its oral insulin capsule.

http://www.drugs.com/clinical_trials/oramed-receives-fda-clearance-initiate-oral-insulin-trials-u-s-15578.html?